Dr. Qiqi Deng is a Director in Clinical Biostatistics at Boehringer Ingelheim Pharmaceutical. She currently coordinates the activities in the Statistical Methodology Team under Therapeutic Area & Methodology Statistics global function, which focuses on statistical methodology innovation in Boehringer Ingelheim. Her main research area includes hypothesis testing and modeling in dose finding, adaptive design, and pragmatic considerations in applying innovative methodology into real clinical studies. She publishes on wide array of statistical topics in her main area and beyond, e.g. multiplicity adjustment, Bayesian statistics. Before she joined the methodology group, she has served as leading statistician for multiple projects, across different clinical development phases and therapeutic areas. Dr. Deng received her bachelor’s degree in Mathematics from Peking University in China, and obtained her Ph. D. in Statistics from University of Minnesota.